Point-of-Care Molecular Diagnostics Manufacturer & Factories

Pioneering the Future of Decentralized Precision Medicine through Advanced IVD Ecosystems and Smart Manufacturing.

🏢Authority in Molecular Innovation

Shenzhen BioX Medical Co., Ltd.

Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.

Global Infrastructure

With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, and biotech companies worldwide.

Core Expertise

The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, and biomarker analysis equipment. We integrate advanced automation and data management to improve testing efficiency and analytical accuracy.

9,000+ Sqm Facility
200+ Global Experts
50+ Countries Served
ISO Certified Quality

📈Evolution of Point-of-Care Molecular Diagnostics

Analyzing the shift from centralized laboratories to real-time, bedside clinical intelligence.

Integration of "Sample-to-Result"

The industry is moving toward fully automated, closed systems that require minimal manual intervention. By integrating lysis, extraction, and amplification into a single cartridge, POC molecular diagnostics are reducing contamination risks and human error.

Multiplexing & Syndromic Panels

Modern clinics demand the ability to test for multiple pathogens simultaneously. Our systems are evolving to provide comprehensive respiratory, gastrointestinal, and STI panels, delivering definitive answers in under 60 minutes.

AI-Driven Diagnostic Insights

Artificial Intelligence is no longer a buzzword but a core component. Algorithms are now used to interpret complex fluorescence curves, ensuring higher sensitivity and specificity in results interpretation, especially in low-resource settings.

🤖China Factory 4.0: Resilient & Efficient Manufacturing

How our Shenzhen-based smart factory ensures global supply chain stability.

Smart Production Lines

At BioX Medical, we utilize Factory 4.0 principles, incorporating IoT sensors and automated assembly robots. This ensures that every molecular diagnostic unit meets rigorous precision standards while maintaining a high throughput to meet sudden global demand surges.

Supply Chain Resilience

Located in the heart of Shenzhen’s biotech cluster, we benefit from an unparalleled ecosystem of component suppliers. This proximity allows us to mitigate logistics risks and maintain a robust inventory of critical reagents and semiconductor parts.

🌍Global Commercial & Industrial Landscape

🏥

Emergency & Urgent Care

In high-pressure ER environments, rapid molecular testing for sepsis or respiratory viruses saves lives. Our portable systems provide gold-standard PCR results in minutes, not days.

✈️

Customs & Border Control

For international travel hubs, BioX Medical provides scalable diagnostic kiosks that ensure biosafety without hindering the flow of global commerce.

🧪

Remote Research Outposts

From environmental monitoring to field epidemiology, our modular energy-saving oxygen generators and diagnostic platforms are designed for rugged, off-grid performance.

🛠️Advanced Engineering & OEM/ODM Versatility

Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.

Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.

Frequently Asked Questions (FAQ)

What makes BioX Medical a leader in POCT Molecular Diagnostics?

Our competitive advantage lies in the integration of high-sensitivity detection with user-friendly automation. Our Shenzhen facility operates under ISO 13485 standards, ensuring that every device delivers lab-grade accuracy in a bedside format.

Do you support customization for international distributors?

Yes, we provide extensive OEM/ODM capabilities. This includes localized software interfaces, customized reagent panels, and co-branded hardware designs to meet specific regional regulatory requirements.

How does your supply chain ensure stability?

By adopting Industry 4.0 practices and leveraging the Shenzhen electronics ecosystem, we maintain a 98% on-time delivery rate even during global logistics fluctuations.

What is the typical turnaround time for molecular results?

Most of our POC systems are designed to provide "sample-to-answer" results within 30 to 60 minutes, significantly faster than traditional centralized lab testing.

Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.

All Point-of-Care Molecular Diagnostics Products